The European Union’s regulatory body on Tuesday announced it received an application from Johnson & Johnson for marketing authorization of its vaccine candidate. Approval would mark the fourth vaccine in the EU’s arsenal against the novel virus.
The European Union’s regulatory body on Tuesday announced it received an application from Johnson & Johnson for marketing authorization of its vaccine candidate. Approval would mark the fourth vaccine in the EU’s arsenal against the novel virus.
